News about Drug Discovery & Development

Gossamer Bio Partners with Chiesi to Develop and Commercialize Seralutinib

Gossamer Bio, Inc. has signed a global collaboration and license deal with Chiesi Farmaceutici to develop and commercialize seralutinib.

Drug Discovery & Development | 07/05/2024 | By Aishwarya |  358

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

VESICA HEALTH, INC., a multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, announced the launch of its laboratory-developed AssureMDx™ test.

Drug Discovery & Development | 06/05/2024 | By Manvi |  618

Lupin Introduces Rymti Biosimilar Etanercept in Canada

Lupin Ltd. has developed Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada (Sandoz).

Drug Discovery & Development | 06/05/2024 | By Aishwarya |  545

Bespak Partners with H and T Presspart to Boost Transition to Low GWP Propellants in pMDIs

Bespak has teamed up with H&T Presspart to accelerate the industry’s transition from existing pressurised Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilising low global warming potential (GWP) propellants.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  416

Dr. Reddys Laboratories Unveils Broad-Spectrum Antibiotics in USA

Dr. Reddy’s Laboratories Ltd. has introduced Doxycycline Capsules, 40 mg in the US market.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  958

ProPharma and PBL Develop Cell and Gene Therapy Manufacturing Device

ProPharma has announced its collaboration with PBL and have jointly developed an enclosed, fully automated cell factory device, the Cell Factory Box (CF Box).

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  504

Astellas Signs License Deal with Poseida to Develop Novel Allogeneic Cell Therapies

Astellas Pharma Inc. has announced that Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas and Poseida have signed a research collaboration and license agreement to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.

Drug Discovery & Development | 03/05/2024 | By Aishwarya |  406

Scenic Biotech Enters into Research Partnership with Bristol Myers Squibb

Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.

Drug Discovery & Development | 01/05/2024 | By Aishwarya |  420

Lupin Launches Mirabegron Extended-Release Tablets in US

Lupin Ltd. has developed Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received approval from the United States Food and Drug Administration (US FDA).

Drug Discovery & Development | 22/04/2024 | By Aishwarya |  571

SII Joins Hands with Univercells to Make Personalized Oncology Affordable

The new therapies are developed using genetic material extracted from the patient’s tumors, a process which is both time-consuming, and expensive.

Drug Discovery & Development | 12/04/2024 | By Manvi |  604